Relative Importance of History of Heart Failure Hospitalization and N-Terminal Pro–B-Type Natriuretic Peptide Level as Predictors of Outcomes in Patients With Heart Failure and Preserved Ejection Fraction-Reference-Cited by-同舟云学术

Relative Importance of History of Heart Failure Hospitalization and N-Terminal Pro–B-Type Natriuretic Peptide Level as Predictors of Outcomes in Patients With Heart Failure and Preserved Ejection Fraction

Published:2015-06 Issue:6 Volume:3 Page:478-486
ISSN:2213-1779
Container-title:JACC: Heart Failure
language:en
Short-container-title:JACC: Heart Failure

Author:

Kristensen Søren L.,Jhund Pardeep S.,Køber Lars,McKelvie Robert S.,Zile Michael R.,Anand Inder S.,Komajda Michel,Cleland John G.F.,Carson Peter E.,McMurray John J.V.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference10 articles.

1. Readmission after hospitalization for congestive heart failure among Medicare beneficiaries;Krumholz;Arch Interm Med,1997

2. Risk following hospitalization in stable chronic systolic heart failure;Abrahamsson;Eur J Heart Fail,2013

3. Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure;Solomon;Circulation,2007

4. Spironolactone for heart failure with preserved ejection fraction;Pitt;N Engl J Med,2014

5. Lessons from the TOPCAT trial;McMurray;N Engl J Med,2014

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of NT-proBNP Levels in the Diagnosis and Treatment of Heart Failure with Preserved Ejection Fraction—It Is Not Always a Hide-and-Seek Game;Journal of Cardiovascular Development and Disease;2024-07-16

2. Clinical characteristics and outcomes of patients hospitalized with heart failure with preserved ejection fraction and low NT-proBNP levels;Medicine;2023-11-24

3. Sacubitril/valsartan in patients with mildly reduced or preserved ejection fraction and worsening heart failure: A review;Terapevticheskii arkhiv;2023-11-03

4. Rationale, Design and Baseline Characteristics of the PARAGLIDE-HF Trial: Sacubitril/Valsartan vs Valsartan in HFmrEF and HFpEF With a Worsening Heart Failure Event;Journal of Cardiac Failure;2023-06

5. Fibroblast growth factor 23 in children with or without heart failure: a prospective study;BMJ Paediatrics Open;2023-02